The Cameco MS Neuroscience Research Centre (CMSNRC) employs 70 principal investigators, research fellows, grad students, technicians and support staff, all with the goal of ending Multiple Sclerosis.
Multiple Sclerosis (MS) is a devastating neurological disorder which strikes during adulthood, often causing problems with vision, body sensation, ability to walk and other critical life functions. The prevalence of MS is high in Canada, and particularly high in Saskatchewan.
Thanks to generous support from Cameco, the CMSNRC was established in 1996 with a mandate to support basic and clinical scientific studies into the cause, treatment and cure of MS and other neurological disorders.
The centre was created by a partnership of the U of S Colleges of Medicine and Dentistry, the MS Society of Canada (Sask. Division), the Saskatoon Health Region (now the Saskatchewan Health Authority), and Saskatoon City Hospital Foundation.
Because of its location at Saskatoon City Hospital, the CMSNRC is part of a distinctive facility. The hospital is also home to the Saskatoon MS Clinic as well as the lab and offices of the Saskatchewan Chair in Multiple Sclerosis Clinical Research, Dr. Michael Levin. Having three such facilities on one site is truly unique.
The professionals at the CMSNRC use basic science research to understand the cellular interactions which govern the normal function of the nervous system and its reaction to disease or injury, and to form the basis for the development of new clinical intervention strategies.
Its association with the MS Clinic in Saskatoon City Hospital provides access to a large MS patient population. While conducting research, the center’s team also strives to better understand the disease and develop treatments that benefit MS patients.
Saskatoon City Hospital Foundation is committed to funding this crucial research facility and its collaborations. Your support of the centre benefits their work. You’re helping to find a cure.
To donate, click here.